News by subject: HEALTH

Aequus Pharmaceuticals Inc. announces that further to our news release dated July 6, 2022, we will resume trading on the TSX Venture exchange tomorrow, July 14, 2022. Doug Janzen noted that "We will be taking steps to lower the risk of this ever...

XORTX Therapeutics Inc. ("XORTX" or the "Company") , a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce positive topline results from Part 1 of the three...

July 13, 2022 Philips demonstrates portfolio of smart connected imaging systems and integrated radiology workflow solutions designed to improve diagnostic confidence and clinical outcomesAmsterdam, the Netherlands and Vienna, Austria ? Royal Philips...

Thanks to an outpouring of community support, Kayla's Children Centre won Trexo Robotics' Canada- wide Trexo Plus Robotic Gait Trainer Giveaway.?  Children with mobility challenges will soon be able to visit Kayla's Children Centre for...

Aviv Clinics highlights a groundbreaking new study that has been published in Scientific Reports, featuring a promising treatment for long COVID symptoms. The study utilizes the most comprehensive evaluation and diagnosis protocol reported in any...

Ayr Wellness Inc. ("Ayr" or the "Company"), a leading vertically integrated U.S. multi-state cannabis operator, announced the opening of AYR in Watertown, the Company's second adult-use dispensary in the Greater Boston area. Sales will begin July...

CQDM, the Quebec Breast Cancer Foundation and Theratechnologies today announced close to CAN $2 million of funding for a collaborative research project that aims to demonstrate the efficacy and safety of a potential innovative treatment for patients...

Helius Medical Technologies, Inc. ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced the launch of its online training module for physical therapists seeking to treat gait deficit in adults with mild...

July 12, 2022  Philips SmartSpeed AI-based software receives FDA 510(k) clearance, delivering breakthrough high-speed, high-resolution MR imaging Unique broad compatibility (97% of clinical protocols) allows faster and high-quality scans for...

TILT Holdings Inc. ("TILT" or the "Company") (NEO: TILT) , a global provider of cannabis business solutions that include inhalation technologies, cultivation, manufacturing, processing, brand development, and the Shinnecock Indian Nation (the...

URAC, the nation's leading health care accreditation and the undisputed leader in telehealth accreditation, announced today that WorldClinic successfully achieved URAC Telehealth Accreditation, solidifying the organization's commitment to the highest...

Today, TELUS Health, together with the National Institute on Ageing (NIA), released the findings from a new survey that sheds light on how older Canadians can be better supported to age well, safely and independently. The 2022 survey of Canadian...

Spectral Medical Inc. ("Spectral" or the "Company") , a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced that the US Food & Drug Administration ("FDA") has granted Breakthrough Device...

Algernon Pharmaceuticals Inc. (the "Company" or "Algernon") , a clinical stage Canadian pharmaceutical development company, is pleased to provide an update on its chronic kidney disease ("CKD") research program with NP-251 ("Repirinast"). In Q1...

FFF Enterprises Inc., the nation's most trusted specialty drug distributor, celebrates 12,419 days of supplying healthcare providers and patients with high-quality, counterfeit-free pharmaceuticals. "I am humbled that today marks 34 years that FFF...

Conagen, the Massachusetts-based biotech firm, announced the commercialization of an expansive portfolio of natural sweetness enhancers for taste modification in sugar reduction solutions for food and beverages. The enhancers are made with precision...

Origin Therapeutics Holdings Inc. (the "Company" or "Origin Therapeutics"), an actively managed, psychedelics industry-focused investment issuer, is pleased to announce that it has added Clairvoyant Therapeutics ("Clairvoyant") to its portfolio....

XORTX Therapeutics Inc. ("XORTX" or the "Company") , a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce that a type B pre-Phase 3 meeting request with...

Consumers add Canadian plant-based foods and beverages to their diets for plenty of reasons, with health and environmental sustainability being among the top cited. Today, consumers can add another reason to their list, as New Protein International...

Shanghai Junshi Biosciences Co., Ltd. ("Junshi Biosciences", HKEX: 1877; SSE: 688180) and Coherus BioSciences, Inc. ("Coherus") announced today that the United States Food and Drug Administration ("FDA") has accepted for review the Biologics...

BetterLife Pharma Inc. ("BetterLife" or the "Company") , an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, is pleased to announce that a joint application to the Mitacs...

Mindset Pharma Inc. ("Mindset" or the "Company"), a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological and psychiatric disorders with unmet medical needs,...

An analysis of data from 21 studies, funded by the Government of Canada through its COVID-19 Immunity Task Force (CITF) and that relied on blood testing, provides a clearer picture of the massive scale of the Omicron wave in Canada. Before the...

A new 2-year infant follow-up study reported no difference in developmental outcomes in children born after capacitation-in vitro maturation (CAPA-IVM) compared to those born through conventional in vitro fertilization (IVF) following ovarian...

OBI Pharma, a Taiwan biopharma company (TPEx: 4174), today announced discontinuation of the Phase 1/2 Study* for OBI 888, a Globo H antibody, upon completion of enrollment in our investigative sites. "We are pleased that the preliminary data from...

A COVID CommUNITY ? South Asian study, published in the Canadian Medical Association Journal (CMAJ) Open has found that South Asian communities living in the Greater Toronto Area (GTA) suffered disproportionately from COVID-19 in the first year of...

Algernon Pharmaceuticals Inc. (the "Company" or "Algernon") a clinical stage pharmaceutical development company is pleased to disclose that as part of its intellectual property patent applications filed in early 2021 for AP-188...

Knight Therapeutics Inc., ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian affiliate, United Medical Ltd., is assuming full commercial activities and is relaunching AKYNZEO® (netupitant /...

July 4, 2022Amsterdam, the Netherlands ? Royal Philips today announced that it has completed the cancellation of 8,758,455 of its shares. The cancelled shares were acquired as part of the EUR 1.5 billion share repurchase program for capital...

June 30, 2022Solution adds proteomic analysis of blood-based biomarkers to Philips Lung Cancer Orchestrator to better assess the risk of lung nodule malignancy, enhancing decision-making for diagnosis and treatment  Amsterdam, the Netherlands ? Royal...

Field Trip Health Ltd. ("Field Trip" or the "Corporation"), a global leader in the development and delivery of psychedelic therapies, today announces that on June 29, 2022, it...

APTIM, a global industry leader in program and construction management for critical infrastructure, received 48 safety awards from the National Safety Council (NSC) in 2021. The awards honor APTIM's company-wide commitment to safety and recognize its...

Achieve Life Sciences, Inc. , a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced it has initiated screening of subjects for the...

Mindset Pharma Inc. ("Mindset" or the "Company"), a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic-inspired medicines to treat neurological and psychiatric disorders with unmet...

PharmaTher Holdings Ltd. (the "Company" or "PharmaTher") , a leader in specialty ketamine pharmaceuticals, is pleased to announce that it has...

Sienna Senior Living Inc. ("Sienna" or the "Company") is pleased to announce the appointment of Dr. Gina Parvaneh Cody to its Board of Directors, effective today. "We are delighted to welcome Dr. Cody to our Board of Directors. Our Company will...

Charmy Pettm, a Canadian pet-nutrition company, announced a Kickstarter campaign for their new line of freeze-dried pet food. The first of its kind in North America, the new line integrates holistic herbs of traditional Chinese medicine into a freeze...

Theralase® Technologies Inc. ("Theralase®" or the "Company") , a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynamic Compounds ("PDCs") and their associated drug formulations, used to...

Axsome Therapeutics, Inc. , a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, is hosting a virtual event today at 9:00 AM EDT to provide investors an update on Sunosi®...

June 28, 2022 Testing in accordance with ISO 18562 and ISO 10993 standards conducted by five certified, independent testing laboratories in the US and Europe Amsterdam, the Netherlands ? On June 14, 2021, Royal Philips'...

Lenica Research Group is pleased to announce the launch of a new strategic partnership with Allegori, a pioneering neuroscience innovation company based in Port of Spain, Trinidad and Tobago. "We're very pleased that Allegori chose Lenica as the...

Curium the world's leading nuclear medicine company, today announced the submission of its Marketing Authorization Application for...

AB-729, our RNAi therapeutic, provided robust and comparable HBsAg declines in both HBeAg+ and HBeAg- patients 50% (16 out of 32) of patients maintained HBsAg levels below 100 IU/mL 24 weeks after their last AB-729 dose In the first five patients...

As the Premier of Ontario announces a new cabinet today, over 160 health workers from across the province have signed onto an open letter calling on the government to legislate at least 10 paid sick days immediately. This is especially pressing given...

Gundry MDtm Bio Complete 3, one of the brand's best selling supplements, now has over 900 positive customer reviews across multiple platforms. Crafted by world-renowned heart surgeon and medical researcher Dr. Steven Gundry, this innovative,...

Theralase® Technologies Inc. ("Theralase" or the "Company") , a clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic Compounds ("PDC") and their associated drug formulations intended to...

LifeLabs has partnered with Indspire to provide scholarships to First Nations, Inuit or Métis students over the course of the next five years. Through its contributions, LifeLabs will support multiple scholarships worth $5,000-$10,000 per student per...

Today, Pharma Intelligence, a leading provider of specialist intelligence, data and software for clinical trials, development and regulatory compliance, announces that it has rebranded to become Citeline. The rebrand follows leading global growth...

Skymount Medical, a drug discovery company using a highly predictive artificial intelligence (AI) platform to repurpose and build new drugs and innovative therapies, announced today that leading pharmaceutical industry executive, Bruce D. Forrest,...

Today, TELUS Health issued its annual 2022 Drug Data Trends and National Benchmarks Report, revealing that while fewer Canadians submitted prescription drug claims in 2021, there was a noticeable increase in the number of claims for mental health...